Akso Health (AHG) Common Equity (2017 - 2026)

Akso Health (AHG) has reported Common Equity for 10 consecutive years, with $180.9 million the latest figure, recorded in Q1 2026.

• Quarterly Common Equity fell 9.15% year-over-year to $180.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.9 million (down 9.15% YoY) and the FY2026 annual result came in at $180.9 million, down 9.15% from the prior year.
• Common Equity retreated to $180.9 million in Q1 2026 per AHG's latest filing, from $198.3 million in the prior quarter.
• Over the last five years, Common Equity for AHG reached as high as $200.7 million in Q3 2024 and fell as low as $5.3 million in Q3 2023.
• A 5-year average of $106.0 million and a median of $138.4 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity sank 49.21% — and 2024, when it jumped 3663.53%.
• Year by year, Common Equity stood at $9.9 million in 2022, then sank by 46.31% to $5.3 million in 2023, then soared by 3663.53% to $200.7 million in 2024, then decreased by 1.17% to $198.3 million in 2025, then declined by 8.76% to $180.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $180.9 million, $198.3 million, and $199.2 million for Q1 2026, Q3 2025, and Q1 2025 respectively.